Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.53B |
| 2 |
NVIDIA
NVDA
|
+$1.07B |
| 3 |
Capital One
COF
|
+$1.02B |
| 4 |
Apple
AAPL
|
+$998M |
| 5 |
Amazon
AMZN
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$671M |
| 3 |
Coca-Cola
KO
|
+$501M |
| 4 |
Qualcomm
QCOM
|
+$435M |
| 5 |
Applovin
APP
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.45% |
| 2 | Financials | 14.05% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Vivos Therapeutics
VVOS
$3.99M
| $183K | ﹤0.01% |
57,902
+553
| +1% | +$1.4K |
|
3902
Allot
ALLT
$377M
| $183K | ﹤0.01% |
21,349
+87
| +0.4% | +$626 |
|
3903
Crescent Capital BDC
CCAP
$409M
| $182K | ﹤0.01% |
12,883
| – | – |
|
3904
Relmada Therapeutics
RLMD
$505M
| $182K | ﹤0.01% |
302,354
+471
| +0.2% | +$242 |
|
|
NINE
3905
DELISTED
Nine Energy Service
NINE
| $181K | ﹤0.01% |
234,709
-274
| -0.1% | -$201 |
|
3906
FibroBiologics
FBLG
$7.32M
| $180K | ﹤0.01% |
14,447
-16,285
| -53% | -$294K |
|
3907
Fractyl Health
GUTS
$111M
| $179K | ﹤0.01% |
110,484
-404,971
| -79% | -$654K |
|
|
OPI
3908
DELISTED
Office Properties Income Trust
OPI
| $179K | ﹤0.01% |
724,585
-165,323
| -19% | -$46.5K |
|
3909
Bridgford Foods
BRID
$57.4M
| $179K | ﹤0.01% |
22,652
+85
| +0.4% | +$674 |
|
3910
Serina Therapeutics
SER
$41.5M
| $178K | ﹤0.01% |
28,884
-322
| -1% | -$1.83K |
|
3911
Hydrofarm Holdings
HYFM
$8M
| $178K | ﹤0.01% |
47,545
-1,486
| -3% | -$4.66K |
|
3912
POET Technologies
POET
$1.53B
| $177K | ﹤0.01% |
34,039
+139
| +0.4% | +$585 |
|
3913
Prelude Therapeutics
PRLD
$456M
| $176K | ﹤0.01% |
217,568
-187,387
| -46% | -$162K |
|
3914
Lisata Therapeutics
LSTA
$10.6M
| $176K | ﹤0.01% |
61,082
+553
| +0.9% | +$1.33K |
|
3915
AudioCodes
AUDC
$257M
| $176K | ﹤0.01% |
17,874
+73
| +0.4% | +$668 |
|
3916
Bridgeline Digital
BLIN
$14M
| $175K | ﹤0.01% |
125,737
+4,070
| +3% | +$6.63K |
|
3917
Bioceres Crop Solutions
BIOX
$24.2M
| $175K | ﹤0.01% |
39,087
+160
| +0.4% | +$721 |
|
|
ISPO
3918
DELISTED
Inspirato
ISPO
| $174K | ﹤0.01% |
50,960
+3,666
| +8% | +$13.5K |
|
|
ZYBT
3919
Zhengye Biotechnology Holding
ZYBT
$72.5M
| $174K | ﹤0.01% |
+29,068
| New | +$231K |
|
|
SY
3920
So-Young International
SY
$227M
| $173K | ﹤0.01% |
55,857
+228
| +0.4% | +$224 |
|
|
ADUR
3921
Aduro Clean Technologies
ADUR
$545M
| $172K | ﹤0.01% |
+19,232
| New | +$132K |
|
|
SLN
3922
Silence Therapeutics
SLN
$642M
| $171K | ﹤0.01% |
29,538
+121
| +0.4% | +$519 |
|
3923
NexGel
NXGL
$3.78M
| $171K | ﹤0.01% |
66,369
-78
| -0.1% | -$195 |
|
|
RVPH
3924
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $171K | ﹤0.01% |
22,410
+1,453
| +7% | +$22.6K |
|
|
TDAC
3925
Translational Development Acquisition Corp
TDAC
$238M
| $171K | ﹤0.01% |
16,554
+68
| +0.4% | +$691 |
|
Similar funds
Geode Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Geode Capital Management held 4,594 positions worth $1.43T, up 12% from $1.27T the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Geode Capital Management's Q2 2025 filing shows 119 new, 2,787 increased, 1,425 reduced and 150 closed positions. Its largest new stake was Emera Inc: 3,219,448 shares worth $152M. The largest sale was Discover Financial Services, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q2 2025 buy was Emera Inc: 3,219,448 shares worth $152M.
- Geode Capital Management added most to Microsoft in Q2 2025, an estimated $1.53B increase.
- Geode Capital Management's biggest Q2 2025 reduction was Palantir, cutting an estimated $671M.
- Geode Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $1.09B.
- Geode Capital Management's ten largest holdings make up 32% of its $1.43T portfolio in Q2 2025.
- Geode Capital Management opened 119 new positions and closed 150 in Q2 2025.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $1.43T.
Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.